Pioneering clinical trial testing how personalised mRNA vaccines can enable the immune system to target recurring pancreatic cancer.

Vaxart Inc (VXRT) reports a remarkable revenue increase and strategic collaborations, despite facing challenges in vaccine trial timelines.

Topline data from 400-person sentinel cohort of the Phase 2b COVID-19 trial anticipated early Q2 2026 Published positive clinical results in the first quarter of 2026 demonstrating oral norovirus ...

A MAN who inflicted “atrocities” on another person has been jailed. Marc Blythin, 44, of Minffordd Street in Corris, near Machynlleth, was sentenced to four years and nine months' imprisonment at ...

After the United States government released its latest tranche of files on Jeffrey Epstein, Sri Lankan social media users claimed the documents revealed email conversations between Bill Gates and the ...

Many pandemic viruses emerged naturally – but there’s one that most likely came from a lab - Research provides benchmark for distinguishing natural outbreaks from scenarios involving lab leaks ...

Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and ...

Despite headwinds, infectious disease research continues. New treatment options for dengue fever are on the horizon, while ...

If the rest of 2026 continues in this vein, we may look back on January and February as the moment the sector recognised that ...

As health care systems around the world come under strain, physicians are turning to a much older form of social medicine.